225 related articles for article (PubMed ID: 36285777)
1. Hypoxia-Responsive Photosensitizer Targeting Dual Organelles for Photodynamic Therapy of Tumors.
Tang Y; Wang X; Zhu G; Liu Z; Chen XM; Bisoyi HK; Chen X; Chen X; Xu Y; Li J; Li Q
Small; 2023 Jan; 19(1):e2205440. PubMed ID: 36285777
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Programmable DNA Nanotrain for Activatable Hypoxia Imaging and Mitochondrion-Targeted Enhanced Photodynamic Therapy.
Liu J; Ding G; Chen S; Xue C; Chen M; Wu X; Yuan Q; Zheng J; Yang R
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9681-9690. PubMed ID: 33606499
[TBL] [Abstract][Full Text] [Related]
3. Development of an Azo-Based Photosensitizer Activated under Mild Hypoxia for Photodynamic Therapy.
Piao W; Hanaoka K; Fujisawa T; Takeuchi S; Komatsu T; Ueno T; Terai T; Tahara T; Nagano T; Urano Y
J Am Chem Soc; 2017 Oct; 139(39):13713-13719. PubMed ID: 28872304
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment-triggered dual-activation of a photosensitizer- fluorophore conjugate for tumor specific imaging and photodynamic therapy.
Wang C; Wang S; Wang Y; Wu H; Bao K; Sheng R; Li X
Sci Rep; 2020 Jul; 10(1):12127. PubMed ID: 32699340
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy.
Liu M; Li C
Chempluschem; 2020 May; 85(5):948-957. PubMed ID: 32401421
[TBL] [Abstract][Full Text] [Related]
6. Aggregation-Induced emission photosensitizer with lysosomal response for photodynamic therapy against cancer.
Pan Z; Wang Y; Chen N; Cao G; Zeng Y; Dong J; Liu M; Ye Z; Li Y; Huang S; Lu YJ; He Y; Liu X; Zhang K
Bioorg Chem; 2023 Mar; 132():106349. PubMed ID: 36716644
[TBL] [Abstract][Full Text] [Related]
7. Novel Lysosome-Targeting Fluorescence Off-On Photosensitizer for Near-Infrared Hypoxia Imaging and Photodynamic Therapy In Vitro and In Vivo.
Ding S; Yang M; Lv J; Li H; Wei G; Gao J; Yuan Z
Molecules; 2022 May; 27(11):. PubMed ID: 35684397
[TBL] [Abstract][Full Text] [Related]
8. Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy.
Ihsanullah KM; Kumar BN; Zhao Y; Muhammad H; Liu Y; Wang L; Liu H; Jiang W
Biomaterials; 2020 Jul; 245():119982. PubMed ID: 32224374
[TBL] [Abstract][Full Text] [Related]
9. A glutathione-responsive photosensitizer with fluorescence resonance energy transfer characteristics for imaging-guided targeting photodynamic therapy.
Cao JJ; Zhang MS; Li XQ; Yang DC; Xu G; Liu JY
Eur J Med Chem; 2020 May; 193():112203. PubMed ID: 32197150
[TBL] [Abstract][Full Text] [Related]
10. Enhancing near-infrared AIE of photosensitizer with twisted intramolecular charge transfer characteristics via rotor effect for AIE imaging-guided photodynamic ablation of cancer cells.
Wang DH; Chen LJ; Zhao X; Yan XP
Talanta; 2021 Apr; 225():122046. PubMed ID: 33592768
[TBL] [Abstract][Full Text] [Related]
11. An intelligent dual stimuli-responsive photosensitizer delivery system with O
Zhao H; Li L; Zheng C; Hao Y; Niu M; Hu Y; Chang J; Zhang Z; Wang L
Colloids Surf B Biointerfaces; 2018 Jul; 167():299-309. PubMed ID: 29679806
[TBL] [Abstract][Full Text] [Related]
12. A hypoxia-activatable theranostic agent with intrinsic endoplasmic reticulum affinity and type-I photosensitivity.
Zhang J; Zhang Y; Zhang H; Zhai W; Shi X; Li C
J Mater Chem B; 2023 May; 11(18):4102-4110. PubMed ID: 37165899
[TBL] [Abstract][Full Text] [Related]
13. Specific light-up bioprobe with aggregation-induced emission and activatable photoactivity for the targeted and image-guided photodynamic ablation of cancer cells.
Yuan Y; Zhang CJ; Gao M; Zhang R; Tang BZ; Liu B
Angew Chem Int Ed Engl; 2015 Feb; 54(6):1780-6. PubMed ID: 25504495
[TBL] [Abstract][Full Text] [Related]
14. New strategy for precise cancer therapy: tumor-specific delivery of mitochondria-targeting photodynamic therapy agents and in situ O
Chen H; He C; Chen T; Xue X
Biomater Sci; 2020 Jul; 8(14):3994-4002. PubMed ID: 32573618
[TBL] [Abstract][Full Text] [Related]
15. Antibody guided activatable NIR photosensitizing system for fluorescently monitored photodynamic therapy with reduced side effects.
Thankarajan E; Tuchinsky H; Aviel-Ronen S; Bazylevich A; Gellerman G; Patsenker L
J Control Release; 2022 Mar; 343():506-517. PubMed ID: 35150812
[TBL] [Abstract][Full Text] [Related]
16. Activation by Glutathione in Hypoxic Environment of an Azo-based Rhodamine Activatable Photosensitizer. A Computational Elucidation.
Ponte F; Mazzone G; Russo N; Sicilia E
Chemistry; 2022 Mar; 28(13):e202104083. PubMed ID: 35040535
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Hypoxia-Overcoming Strategy of Aggregation-Induced Emission Photosensitizers for Efficient Photodynamic Therapy.
Chen H; Wan Y; Cui X; Li S; Lee CS
Adv Healthc Mater; 2021 Dec; 10(24):e2101607. PubMed ID: 34674386
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble red fluorescent protein dimers for hypoxic two-photon photodynamic therapy.
Feng W; Qian Y
J Mater Chem B; 2024 Feb; 12(9):2413-2424. PubMed ID: 38354026
[TBL] [Abstract][Full Text] [Related]
19. Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.
Ren C; Xu X; Yan D; Gu M; Zhang J; Zhang H; Han C; Kong L
Acta Biomater; 2022 Jul; 146():465-477. PubMed ID: 35526738
[TBL] [Abstract][Full Text] [Related]
20. Transporting mitochondrion-targeting photosensitizers into cancer cells by low-density lipoproteins for fluorescence-feedback photodynamic therapy.
Wang C; Zhao X; Jiang H; Wang J; Zhong W; Xue K; Zhu C
Nanoscale; 2021 Jan; 13(2):1195-1205. PubMed ID: 33404030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
